The effect of age on first-line sunitinib treatment in patients with renal cell carcinoma (RCC).

e15096 Background: Sunitinib is a first line treatment for majority of patients with metastatic RCC. The recommended dose of 50mg often results in a spectrum of serious side effects which subsequen...